Investigators have revealed that Forteo or injectable Teriparatide is better than Fosamax or oral Alendronate when it comes to enhancing the level of bone mineral density (BMD) by as much as two times, in a head-to-head comparison.
Philip N. Sambrook, M.D., of the University of Sydney, remarked that teriparatide can be prescribed as a first-line therapy [...]
August 2, 2010 | Posted in
Steroids Blog |
Read More »
Investigators have found, in a head-to-head comparison, that injectable teriparatide (Forteo) is able to increase bone mineral density (BMD) by as much as twice when compared to oral alendronate (Fosamax).
Teriparatide is associated with greater improvements in BMD at the spine and the hip, as per Kenneth Saag, M.D., of the [...]
June 29, 2010 | Posted in
Steroids Blog |
Read More »
Osteoporosis induced by steroids can be better treated with Teriparatide, a synthetic form of the human parathyroid hormone, than Alendronate.
The involved researchers remarked that patients with osteoporosis patients when treated with teriparatide for a period of 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral [...]
June 7, 2010 | Posted in
Steroids Blog |
Read More »
Bone mineral density (BMD) is increased by as much as 2 percent by injectable teriparatide (foreto) when compared to oral alendronate (fosamax) in a head-to-head comparison, as per a recent study.
Kenneth Saag, M.D., of the University of Alabama at Birmingham and his colleagues, said that teriparatide is effective for ensuring improvements in BMD level at [...]
February 9, 2010 | Posted in
Steroids Blog |
Read More »
Teriparatide, which is a synthetic form of the human parathyroid hormone, is a better form of treating glucocorticoid-induced (OP) than alendronate, as per a recent study.
The involved researchers found out that patients suffering from glucocorticoid-induced osteoporosis and treated with teriparatide for a period of 36 months show significant improvements in terms of BMD (bone mineral [...]
January 27, 2010 | Posted in
Steroids Blog |
Read More »
Glucocorticoid-induced osteoporosis (OP) can be effectively treated with a synthetic form of the human parathyroid hormone, Teriparatide. This finding was published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
Glucocorticoids are steroid hormones that are naturally produced in the human body and may be termed as synthetically [...]
December 30, 2009 | Posted in
Steroids Blog |
Read More »
Teriparatide, a synthetic form of the human parathyroid hormone, can prove its worth when it comes to effectively treating glucocorticoid-induced osteoporosis (OP), as per a recent study.
The involved researchers remarked that patients with glucocorticoid-induced OP and treated with teriparatide for a period of 36 months tend to experience fewer new vertebral fractures and increased BMD [...]
December 2, 2009 | Posted in
Steroids Blog |
Read More »
According to a recent study, injectable version of teriparatide (foreto) is able to increase BMD (bone mineral density) by as much as two percent as compared to oral alendronate (fosamax) in a head-to-head comparison.
Teriparatide was seen in a relationship with enhanced improvements in bone mineral density level at the spine and hip, as per Kenneth [...]
October 30, 2009 | Posted in
Steroids Blog |
Read More »
